Word

CHONDROTISSUE

Status

Dead

Status Code

404

Status Date

Friday, December 23, 2016

Serial Number

79034419

Registration Number

3520741

Registration Date

Tuesday, October 21, 2008

Mark Type

3000

Filing Date

Friday, December 22, 2006

Published for Opposition

Tuesday, August 5, 2008

Cancellation Date

Friday, December 23, 2016

Trademark Owner History

BioTissue AG -
BioTissue Technologies GmbH - Original Registrant

Classifications

5 Polymer-based pharmaceutical preparations for use in tissue and organ transplantation, namely, regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers; biomedical polymer-based pharmaceutical preparations, namely, preparations for use in tissue and organ transplantation, namely regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers

10 Medical devices in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; surgical implants primarily comprising artificial tissue, also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological surgical implants primarily comprising artificial tissue also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; health care products in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; products of tissue engineering, namely, surgical implants and modified surgical implants primarily comprising artificial material, also consisting of biological materials, all sold as a unit; tissue precursors, namely, surgical implants primarily comprising artificial material also consisting of molecules, namely, hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof produced in vitro for replacing and supporting the function of absent or injured body parts, all sold as a unit; artificial cartilage replacements and tissue replacements, namely, primarily artificial substitutes for bones, cartilage, ligaments, and tendons, also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological replacement and biological protection of mesenchymal tissue, namely, primarily artificial substitutes for bones, cartilage, ligaments and tendons also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit

42 Research and development of pharmaceutical preparations and medicines; consultancy in the field of biomedicine

Color is not claimed as a feature of the mark.
"CHONDROTISSUE"
The mark consists of a circle separated into two parts by a curvilinear line next to the term "CHONDROTISSUE".

Trademark Events

Sep 28, 2018

Notification Of Effect Of Cancellation Of Intl Reg Mailed

Sep 28, 2018

Death Of International Registration

Oct 21, 2016

Total Invalidation Processed By The Ib

Mar 28, 2016

Total Invalidation Of Reg Ext Protection Sent To Ib

Mar 28, 2016

Invalidation Processed

Jan 22, 2016

Total Invalidation Of Reg Ext Protection Created

May 22, 2015

Cancelled Section 71

Jan 5, 2013

Final Decision Transaction Processed By Ib

Feb 4, 2010

Change Of Owner Received From Ib

Jan 30, 2009

Final Disposition Notice Sent To Ib

Jan 30, 2009

Final Disposition Processed

Jan 21, 2009

Final Disposition Notice Created, To Be Sent To Ib

Oct 21, 2008

Registered-Principal Register

Aug 22, 2008

Notification Of Possible Opposition - Processed By Ib

Aug 7, 2008

Notification Of Possible Opposition Sent To Ib

Aug 7, 2008

Notification Of Possible Opposition Created, To Be Sent To Ib

Aug 5, 2008

Published For Opposition

Jul 16, 2008

Notice Of Publication

Jun 30, 2008

Law Office Publication Review Completed

Jun 27, 2008

Examiners Amendment Mailed

Jun 27, 2008

Approved For Pub - Principal Register

Jun 27, 2008

Examiner's Amendment Entered

Jun 27, 2008

Examiners Amendment -Written

Jun 26, 2008

Teas/Email Correspondence Entered

Jun 26, 2008

Correspondence Received In Law Office

Jun 26, 2008

Teas Request For Reconsideration Received

Dec 26, 2007

Final Refusal Mailed

Dec 22, 2007

Final Refusal Written

Dec 21, 2007

Amendment From Applicant Entered

Oct 19, 2007

Correspondence Received In Law Office

Dec 21, 2007

Legal Instrument Examiner (Lie) - Correction

Nov 28, 2007

Response To Itu Office Action Entered

Nov 28, 2007

Assigned To Lie

Oct 19, 2007

Paper Received

Jul 12, 2007

New Representative At Ib Received

May 3, 2007

Refusal Processed By Ib

Apr 19, 2007

New Representative At Ib Received

Apr 18, 2007

Non-Final Action Mailed - Refusal Sent To Ib

Apr 18, 2007

Refusal Processed By Mpu

Apr 18, 2007

Non-Final Action (Ib Refusal) Prepared For Review

Apr 17, 2007

Non-Final Action Written

Apr 17, 2007

Assigned To Examiner

Mar 1, 2007

New Application Entered In Tram

Mar 1, 2007

Sn Assigned For Sect 66a Appl From Ib